MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the ...

MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

MeiraGTx Holdings plc stock surges after a major Eli Lilly partnership boosts funding and pipeline. Click for my updated look ...

ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced that the company will deliver ...

Positive 3-month pediatric and 18-month adult clinical data from OPGx-LCA5 Phase 1/2 trial support the potential for restoring cone-mediated ...

MCO-010, an optogenetic therapy, demonstrated long-term safety and improved quality of life in patients with retinitis ...

A groundbreaking electronic eye implant has offered a ray of hope to patients suffering from age-related macular degeneration ...

Children between the ages of 3 and 6 years old should undergo vision screening at least once a year, according to new ...

The ADA is clear: Determining disability is a medical question, not a judicial one. Whether someone has ADD, PTSD or a brain ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...

Sufficient evidence supported a federal jury’s findings that a Tennessee county health employee’s asthma and trouble seeing ...

Kenyan students Purity Nduku and Blessing Cheroo, who go to a boarding school for blind and partially blind children near ...